Finally, in a matched-controlled clinical study, Ali et al. in 2014 showed that IGF-1 played an important role in developing BPH in type 2 diabetic patients with low PSA levels (between 0.7 and 2.4 ng/mg) [48]. This evidence concerns the gene IGF1 and benign prostatic hyperplasia.